Explain this page
Arphra AIPlain-English read on PetMed Express, Inc.’s valuationRatios & metrics
Profitability, returns on capital, growth, and credit — all derived from the historical income statement, balance sheet, and cash flow rows in our data warehouse.
A snapshot of the latest fiscal year’s margins, returns on capital, balance-sheet strength and efficiency, computed from the income statement, balance sheet and cash-flow rows. Source income / balance / cash_flow.
Valuation multiples
| In USD | FY 2026 | 2027E | 2028E |
|---|---|---|---|
| Headline | |||
| Market cap | $47.7M | — | — |
| Enterprise value | $26.82M | — | — |
| Multiples | |||
| P / E | — | — | — |
| P / B | — | — | — |
| EV / EBITDA | — | — | — |
| EV / Sales | 0.15 | — | — |
| EV / FCF | -0.81 | — | — |
| Yields | |||
| Earnings yield | -120.09% | — | — |
| Free cash flow yield | -69.20% | — | — |
| Dividend yield | — | — | — |
Profitability
| In USD | FY 2026 | 2027E | 2028E |
|---|---|---|---|
| Margins | |||
| Gross margin | +28.05% | +27.38% | +28.22% |
| Operating margin | -17.55% | -17.90% | -17.59% |
| EBITDA margin | -12.30% | -11.98% | -12.49% |
| EBIT margin | -17.55% | -17.21% | -17.57% |
| Pre-tax margin | -32.04% | -32.86% | -32.03% |
| Net margin | -32.00% | -31.61% | -31.82% |
| Cost structure | |||
| Cost of revenue / sales | +71.95% | +73.04% | +70.87% |
| R&D intensity | 0.00% | 0.00% | 0.00% |
| SG&A intensity | +40.36% | +39.47% | +40.03% |
| Effective tax rate | — | — | — |
Returns on capital
| In USD | FY 2026 | 2027E | 2028E |
|---|---|---|---|
| Returns | |||
| Return on equity (ROE) | -197.95% | -192.23% | -202.54% |
| Return on assets (ROA) | -70.56% | -69.91% | -68.23% |
| Return on capital (ROC) | -106.58% | -106.88% | -109.93% |
| Return on invested capital (ROIC) | -79.94% | -80.16% | -82.45% |
| Asset turnover | +220.49% | +221.13% | +214.45% |
| DuPont · ROE decomposition | |||
| Net margin | -32.00% | -31.61% | -31.82% |
| Asset turnover (× revenue / assets) | +220.49% | +221.13% | +214.45% |
| Equity multiplier (× assets / equity) | +280.55% | +274.98% | +296.86% |
Activity & efficiency
| In USD | FY 2026 | 2027E | 2028E |
|---|---|---|---|
| Turnover | |||
| Asset turnover | 2.20 | 2.21 | 2.14 |
| Fixed-asset turnover | 6.67 | — | — |
| Inventory turnover | 9.47 | — | — |
| Receivables turnover | 93.83 | — | — |
| Payables turnover | 6.16 | — | — |
| Days outstanding | |||
| Days sales outstanding (DSO) | 3.89 | — | — |
| Days inventory outstanding (DIO) | 38.56 | — | — |
| Days payables outstanding (DPO) | 59.24 | — | — |
| Cash conversion cycle | -16.79 | — | — |
Cash flow quality
| In USD | FY 2026 | 2027E | 2028E |
|---|---|---|---|
| Operating CF / Net income | 0.50 | 0.50 | 0.51 |
| FCF / Net income | 0.58 | 0.58 | 0.58 |
| FCF margin | -18.44% | -18.42% | -18.59% |
| OCF margin | -15.86% | -15.89% | -16.12% |
| CapEx / Revenue | +2.58% | +2.55% | +2.60% |
| CapEx / D&A | 0.49 | — | — |
| Stock-based comp / Revenue | +0.76% | — | — |
Per-share & shareholder yield
| In USD | FY 2026 | 2027E | 2028E |
|---|---|---|---|
| EPS · diluted | -2.74 | 0.07 | 0.09 |
| EPS · basic | -2.74 | 0.07 | 0.09 |
| Book value / share | 1.38 | 1.43 | 1.39 |
| Tangible BV / share | 0.87 | 1.43 | 1.39 |
| Sales / share | 8.56 | 8.69 | 8.84 |
| Operating CF / share | -1.36 | -1.38 | -1.43 |
| Free cash flow / share | -1.58 | -1.60 | -1.64 |
| Dividends / share | 0.00 | 0.00 | 0.00 |
| Payout ratio | -0.04% | -0.04% | -0.04% |
| Retention ratio | +100.04% | +100.04% | +100.04% |
Growth
| In USD | FY 2026 | 2027E | 2028E | 2y CAGR |
|---|---|---|---|---|
| Top-line | ||||
| Revenue · YoY | — | +0.73% | +2.26% | +1.49% |
| Gross profit · YoY | — | -1.68% | +5.40% | +1.80% |
| Profit | ||||
| Operating income · YoY | — | -2.73% | -0.50% | — |
| EBITDA · YoY | — | +1.89% | -6.55% | — |
| Net income · YoY | — | +0.49% | -2.91% | — |
| Operating | ||||
| EBIT · YoY | — | +1.22% | -4.40% | — |
| R&D · YoY | — | — | — | — |
| Per-share | ||||
| EPS · diluted · YoY | — | +102.55% | +28.57% | — |
| EPS · basic · YoY | — | +102.56% | +28.61% | — |
Credit & leverage
| In USD | FY 2026 | 2027E | 2028E |
|---|---|---|---|
| Leverage | |||
| Total debt | $535K | $541.39K | $540.08K |
| Net debt | -$20.88M | -$21.12M | -$21.42M |
| Net debt / EBITDA | 0.95 | 0.98 | 0.93 |
| Debt / equity | 0.02 | 0.02 | 0.02 |
| Debt / assets | +0.66% | +0.66% | +0.63% |
| Equity / assets | +35.64% | +36.37% | +33.69% |
| Coverage | |||
| EBITDA / interest expense | — | — | — |
| Operating income / interest | — | — | — |
| Interest expense | $0 | $0 | $0 |
| Liquidity | |||
| Current ratio | 0.84 | — | — |
| Quick ratio | 0.45 | — | — |
| Cash ratio | 0.41 | — | — |
| Working capital | -$8.47M | — | — |
| Working capital / revenue | -4.73% | — | — |
Historical multiples · μ ± σ bands
3 fiscal-year-end observations from key_metrics. Mean is dashed; light-green band is ±1σ, light-red band ±2σ. The dot marks the most recent value; the cheap / fair / rich verdict uses z-score against the issuer's own history (yields inverted — a high yield is cheap).
Sourced from key_metrics + financial_ratios (loaded by load_fundamentals_extended.py).
| Metric | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|
| P / E | — | — | — |
| P / B | — | — | — |
| EV / EBITDA | — | — | — |
| EV / Sales | 0.15x | 0.14x | 0.15x |
| Earnings yield | -120.1% | -7.3% | -7.8% |
| FCF yield | -69.2% | -0.5% | -0.2% |
| Metric | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|
| Gross margin | — | — | — |
| Operating margin | — | — | — |
| Net margin | — | — | — |
| ROE | -197.9% | -7.4% | -7.7% |
| ROA | -70.6% | -4.2% | -4.4% |
| ROIC | -105.8% | -1.8% | -7.1% |
| Metric | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|
| Debt / equity | — | — | — |
| Net debt / EBITDA | 0.95 | -8.01 | -68.76 |
| Interest coverage | — | — | — |
| Current ratio | 0.84x | 1.26x | 1.30x |
| Quick ratio | — | — | — |
Methodology. ROE / ROA / ROC use period-end balance-sheet denominators (no average-of- period smoothing). ROIC = Operating Income × (1 − inferred effective tax rate) over invested capital, with the effective tax inferred from net-to-operating income when both are positive and a 25% default otherwise. Net debt / EBITDA, debt ratios, and interest-coverage ratios are calculated point-in-time at each fiscal year-end. TTM = trailing 4 quarters (income / cash flow summed, balance sheet = most-recent quarterly snapshot). Through-cycle CAGR in the Growth panel uses the geometric mean of first-to-last period growth across the window (positive values only).